Policy document
July 28th 2011
Test No. 456: H295R Steroidogenesis Assay
IGO
This Test Guideline describes an in vitro screen for chemical effects on steroidogenesis, specifically the production of 17ß-estradiol (E2) and testosterone (T). The human H295R adreno-carcinoma cell line, used for the assay, expresses genes that encode for all the key enzymes for steroidogenesis. After an acclimation period of 24 h in multi-well plates, cells are exposed for 48 h to seven concentrations of the test chemical in at least triplicate. Solvent and a known inhibitor and inducer of hormone production are run at a fixed concentration as negative and positive controls. At the end of the exposure period, cell viability in each well is analyzed. Concentrations of hormones in the medium can be measured using a variety of methods including commercially available hormone measurement kits and/or instrumental techniques such as liquid chromatography-mass spectrometry. Data are expressed as fold change relative to the solvent control and the Lowest-Observed-Effect-Concentration. If the assay is negative,...
Hello! You're looking at a policy document report on Overton
We track government policy, guidelines, think tank research, working papers and more to help our customers see the impact and influence of their work. Are you interested in seeing what information we have to offer?
If you fund, produce or manage research or work to influence policy, we'd love to talk.
Identifiers
Overton ID
oecddiscovery-e7092fdac3bc7d8b21a064d60ca662b9
Topics in this document
Related COFOG Divisions
Citations
Cited by 22
other policy documents
(19 of them are from other policy sources)